Both in Pharmaceuticals
Kyntra Bio vs Bolt Biotherapeutics
Over the past year KYNB returned −50.3% and BOLT returned +13.3%; their daily moves had a correlation of -0.03.
KYNB −50.3% BOLT +13.3%Growth of $1, one year, split-adjusted
| Metric | KYNB | BOLT |
|---|---|---|
| Price | $4.72 | $6.58 |
| Market cap | $19.1M | $15.5M |
| Today | +4.89% | +3.30% |
| 1 month | −30.5% | +82.8% |
| 6 months | −33.0% | +38.2% |
| Year to date | — | +20.3% |
| 1 year | — | +5.4% |
| Revenue growth (YoY) | — | −99.7% |
| Gross margin | — | 100.0% |
| Net margin | — | −154400.0% |
| P/E (TTM) | — | — |
| Price / sales | — | 3.3× |
| Net cash | $91.3M | $17.6M |
| Dividend yield | — | — |
| Volatility (60d) | 56.1% | 111.3% |
| Short % of float | 2.5% | 1.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).